Effect of CHPPC combined with intravenous chemotherapy on the expression of serum OPN and nm23H1 protein in elderly patients with advanced gastric cancer
YANG Benxin DU Yuan NIE Shuangfa LI Lei FEI Jiandong▲
Graduate School of Hebei North University, Hebei Province, Zhangjiakou 075000, China
Abstract：Objective To analyze the effect of continuous hyperthermic peritoneal perfusion chemotherapy (CHPPC) combined with intravenous chemotherapy on the treatment of elderly patients with gastric cancer and the influence of expression of OPN and nm23H1 protein in the serum of the patients. Methods From January 2016 to January 2017, 80 elderly patients with gastric cancer in the First Affiliated Hospital of Hebei North University were selected, and divided into observation group and control group by random envelope method, with 40 cases in each group. The control group was treated with conventional intravenous chemotherapy, observation group was treated with CHPPC combined with intravenous chemotherapy, and the short-term efficacy of the treatment was evaluated 8 weeks after treatment, the serum CEA CA242, CA199, OPN, nm23H1 protein expression level between two groups were compared. Results After treatment, the total effective rate in observation group was higher than control group, the difference was highly statistically significant (P < 0.01). After treatment, the serum CEA CA242, CA199 level of patients in both groups were lower than those before treatment (P < 0.05), and observation group were lower than those control group (P < 0.05). After treatment, the serum OPN level of patients in both groups was lower than before treatment (P < 0.05), nm23H1 protein expression level was higher than before treatment (P < 0.05), and the serum OPN level in the observation group was lower than control group (P < 0.05), nm23H1 protein expression level was higher than control group (P < 0.05). Conclusion Elderly patients with gastric cancer treated with CHPPC combined with intravenous chemotherapy can effectively improve the clinical efficacy and improve serum OPN and nm23H1 levels, and it has extensive clinical significance.
杨本鑫 杜园 聂双发 李磊 费建东▲. CHPPC联合静脉化疗对老年进展期胃癌患者血清OPN、nm23H1蛋白表达的影响[J]. 中国医药导报, 2018, 15(6): 171-174.
YANG Benxin DU Yuan NIE Shuangfa LI Lei FEI Jiandong▲. Effect of CHPPC combined with intravenous chemotherapy on the expression of serum OPN and nm23H1 protein in elderly patients with advanced gastric cancer. 中国医药导报, 2018, 15(6): 171-174.
[1] Ni X，Wu P，Wu J，et al. Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites [J]. Oncol Lett，2017，14（2）：1691-1696.
[2] 李小攀，陈亦晨，王莉红，等.上海市浦东新区居民2002-2014年胃癌发病情况及其趋势分析[J].中华肿瘤防治杂志，2016，23（8）：479-482.
[3] Ba M，Long H，Zhang X，et al. Hyperthermic intraperitoneal perfusion chemotherapy and cytoreductive surgery for controlling malignant ascites from ovarian cancer [J]. Int J Gynecol Cancer，2016，26（9）：1571-1579.
[4] Zhang T，Pan Q，Xiao S，et al. Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer [J]. Oncol Lett，2016，11（5）：3287-3292.
[5] Lyon TD，Ii RMT，Nikonow TN，et al. Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy [J]. J Surg Oncol，2016，113（2）：218-222.
[6] 牟儒奎，金成勇，姜世平.胃肠癌根治术中持续循环腹腔热灌注化疗的应用效果[J].实用癌症杂志，2017，32（5）：763-766.
[7] 冯奉仪.实体瘤新的疗效评价标准（解读1.1版RECIST标准）[C]//中国肿瘤内科大会.2009.
[8] Lal P，Bansal B，Sharma R，et al. Laparoscopic TEP repair of inguinal hernia does not alter testicular perfusion [J]. Hernia，2016，20（3）：429-434.
[9] 郭建峰.早期循环式腹腔热灌注化疗对胃癌合并腹腔积液的效果及对患者血清MMPs与CEA的影响[J].实用癌症杂志，2016，31（9）：1414-1416.
[10] Janssens MU，Joannidis UMM. Akute kardiorenale Syndrome [J]. Med Klin-Intensivmed，2016，111（4）：1-18.
[11] Ramazani F，van Nostrum CF，Storm G，et al. Locoregional cancer therapy using polymer-based drug depots [J]. Drug Discov Today，2016，21（4）：640-647.
[12] 夏术森，王崇树，张广军，等.梗阻型结直肠癌术中及术后门静脉化疗联合术后FOLFOX4方案化疗对肝脏转移的影响[J].中国普外基础与临床杂志，2016，23（1）：60-64.
[13] Park S，Lee J，Jo MH，et al. In vivo monitoring of angiogenesis in a mouse hindlimb ischemia model using fluorescent peptide-based probes [J]. Amino Acids，2016，48（7）：1-14.
[14] Song K，Liu N，Yang Y，et al. Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262 [J]. Tumour Biol，2016，37（5）：6493-6499.
[15] Yun-Feng，Zhou，Liang，et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies [J]. World J Gastroentero，2016，22（30）：6906-6916.
[16] 李华强，郭春芳.OPN、B7-H4在上皮性卵巢癌患者血清中的表达及临床意义[J].局解手术学杂志，2016，25（12）：867-870.
[17] Sun SJ，Wu CC，Sheu GT，et al. Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth [J]. Oncotarget，2016，7（34）：55 572-55 579.
[18] Ostheimer C，Schweyer F，Reese T，et al. The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer [J]. Oncol Lett，2016，12（5）：3449-3456.
[19] 唐泽飞，李春鸣.nm23重组质粒与肿瘤关系研究进展[J].中华实用诊断与治疗杂志，2016，30（1）：12-14.
[20] Kim I，Cheung DY，Jin IK，et al. Risk factors of lymph node metastasis in undifferentiated early gastric cancers [J]. J Clin Oncol，2017，35（4）：171.
[21] 任羽，贺爱军，葛繁梅.nm23-H1蛋白在急性髓细胞白血病患者中的表达及其疗效[J].实用临床医药杂志，2016， 20（5）：43-45.
[22] 邱亚，杨湛.肿瘤转移抑制基因nm23/NDPK的结构与功能[J].西部医学，2006，18（5）：654-656.
2018, Vol. 15 
京公网安备 11010502046598号